Inhibikase Therapeutics, Inc. - Common Stock (IKT)

1.6700
+0.00 (0.00%)
NASDAQ· Last Trade: Jun 15th, 5:00 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors